The frequency, related cause of disease, and treatment of hepatitis B virus infection: A systematic review and meta-analysis in Iran.

Autor: Kalvandi G; Associate Professor of Pediatrics Gastroenterology Department of Pediatrics, School of Medicine Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran., Abangah G; Associate Professor of Gastroenterology and Hepatology, School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran., Veisani Y; Research Assistant Professor of Epidemiology Department of Epidemiology, School of Health Psychosocial Injuries Research Center Ilam University of Medical Sciences, Ilam, Iran., Nourmohammadi H; Assistant Professor of Hematology and Oncology, Department of Internal Medicine, School of Medicine,Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran., Golitaleb M; Instructor of Critical Care Nursing Department of Nursing, School of Nursing Arak University of Medical Sciences, Arak, Iran., Tavan H; MSs of nursing Medical-Surgical, Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Jazyk: angličtina
Zdroj: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences [J Res Med Sci] 2022 Feb 18; Vol. 27, pp. 15. Date of Electronic Publication: 2022 Feb 18 (Print Publication: 2022).
DOI: 10.4103/jrms.JRMS_67_19
Abstrakt: Background: Hepatitis B virus (HBV) is one of the most dreadful viruses causing high mortality rates and serious damages to hepatocytes. The aim of this study was to assess the frequency, related causes/risk factors, and treatments of HBV infection in Iran by systematic review and meta-analysis.
Materials and Methods: The data were obtained by a literature search in the PubMed, Scopus, SID, and Web of Sciences databases. Keywords included prevalence, risk factors, causes, treatment, and HBV. The Persian equivalents of these keywords were also searched. The time span included 2004 to2021. The Q and I 2 statistics were used to check heterogeneity among studies. The data were analyzed using Stata (version 14).
Results: The frequencies of HBV infection and its pharmaceutical therapy were P = 6% (95% confidence interval [CI]: 4-9, I 2 = 95.2%, P < 0.001) and 19% (95% CI: 18%-30%, I 2 = 98.9%, P < 0.001), respectively. The most common risk factors/causes of HBV were narcotic consumption, blood-related factors, and transmission from infected individuals with the respective frequencies of 27% (95% CI: 16%-38%, I 2 = 88.7%, P < 0.001), 32% (95% CI: 11%-53%, I 2 = 99.8%, P < 0.001), 25% (95% CI: 10%-41%, I 2 = 99.3%, P < 0.001), and 15% (95% CI: 7%-22%, I 2 = 98.4%, P < 0.001), respectively.
Conclusion: The most important causes of HBV infection were transmission from infected people, narcotic consumption, and blood-related factors. The main therapeutic intervention for HBV was pharmaceutical therapy.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2022 Journal of Research in Medical Sciences.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje